These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27500683)

  • 1. Complex Interaction Between Diphenylcyclopropenone and Immune Responses in Alopecia Areata.
    Tavakolpour S; Mahmoudi HR; Daneshpazhooh M; Rahimzadeh G
    Scand J Immunol; 2016 Nov; 84(5):310-311. PubMed ID: 27500683
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Tron V
    J Invest Dermatol; 1995 May; 104(5 Suppl):36S. PubMed ID: 7738390
    [No Abstract]   [Full Text] [Related]  

  • 3. Home-based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic-based treatment in patients with stable disease: A retrospective study of 40 patients.
    Lee S; Lee WS
    J Am Acad Dermatol; 2018 Mar; 78(3):599-601.e1. PubMed ID: 28947296
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: An observational study of nonresponder patients with alopecia areata.
    Wasyłyszyn T; Borowska K
    Australas J Dermatol; 2017 Aug; 58(3):219-223. PubMed ID: 27087586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
    Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
    Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical immunotherapy with diphenylcyclopropenone-induced vitiligo.
    Kutlubay Z; Engin B; Songur A; Serdaroglu S; Tuzun Y
    J Cosmet Laser Ther; 2016 Aug; 18(4):245-6. PubMed ID: 26963903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of alopecia areata with diphenylcyclopropenone.
    Kietzmann H; Hardung H
    Acta Derm Venereol; 1985; 65(3):274-5. PubMed ID: 2411093
    [No Abstract]   [Full Text] [Related]  

  • 8. Alopecia areata in a patient with candidiasis-endocrinopathy syndrome: unsuccessful treatment trial with diphenylcyclopropenone.
    Böni R; Trüeb RM; Wüthrich B
    Dermatology; 1995; 191(1):68-71. PubMed ID: 8589491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine patterns in alopecia areata before and after topical immunotherapy.
    Happle R; Hoffmann R
    J Invest Dermatol; 1995 May; 104(5 Suppl):14S-15S. PubMed ID: 7537782
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of alopecia areata with diphenylcyclopropenone.
    Hull SM; Cunliffe WJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):276-7. PubMed ID: 1552076
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese experience in the treatment of alopecia areata with diphenylcyclopropenone.
    Pan R; Liu J; Xuan X; Li B
    J Dermatol; 2015 Feb; 42(2):220-1. PubMed ID: 25545114
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of alopecia areata with topical sensitizers.
    Sutherland L; Laschinger M; Syed ZU; Gaspari A
    Dermatitis; 2015; 26(1):26-31. PubMed ID: 25581667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata.
    Jang YH; Jung HJ; Moon SY; Lee WJ; Lee SJ; Lee WK; Kim DW
    J Am Acad Dermatol; 2017 Jul; 77(1):170-172.e1. PubMed ID: 28619558
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment for facial alopecia areata: A systematic review with evidence-based analysis.
    Murad A; Bergfeld W
    J Am Acad Dermatol; 2018 Mar; 78(3):601-605. PubMed ID: 28987491
    [No Abstract]   [Full Text] [Related]  

  • 18. Blockage of T Cell Activation via Anti-CD40 and Anti-CD154 Monoclonal Antibodies can Possibility Treat Alopecia Areata.
    Tavakolpour S; Daneshpazhooh M; Mahmoudi HR
    Scand J Immunol; 2016 Jun; 83(6):463-4. PubMed ID: 26972309
    [No Abstract]   [Full Text] [Related]  

  • 19. Alopecia Areata-Part III: Prognosis and Treatment.
    Estefan J; Ribeiro M; Abad E; Saintive S; Ramos-E-Silva M
    Skinmed; 2016; 14(5):361-365. PubMed ID: 27871349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythema Multiforme Major After Immunotherapy With Diphenylcyclopropenone for Alopecia Areata.
    Sanger J; Zahir A; Driscoll M; Gaspari AA
    Dermatitis; 2018; 29(6):348-349. PubMed ID: 30346328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.